News

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...
Of multiple employees accused of sexual abuse at a now-closed Florida juvenile justice center, a lawsuit brought by five survivors says one staffer had girls who objected to abuse, or ...
The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...
I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...
Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Lawsuits are piling up as weight-loss drug users report losing their sight: ‘I definitely wouldn’t have taken it’ - Edward ...